Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Stitt
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Aminoguanidine Treatment Inhibits the Development of Experimental Diabetic Retinopathy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Correction: Aminoguanidine Teatment Inhibits the Development of Experimental Diabetic Retinopathy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Novel Inhibitor of Advanced Glycation End-Product Formation Inhibits Mesenteric Vascular Hypertrophy in Experimental Diabetes
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Aminoguanidine Inhibits the Development of Accelerated Diabetic Retinopathy in the Spontaneous Hypertensive Rat
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Metabolic Interactions of AGE Inhibitor Pyridoxamine and Antioxidant Α-Lipoic Acid Following 22 Weeks of Treatment in Obese Zucker Rats
Life Sciences
Genetics
Molecular Biology
Pharmacology
Biochemistry
Medicine
Toxicology
Pharmaceutics
The Retinal Proteome in Experimental Diabetic Retinopathy
Molecular and Cellular Proteomics
Biochemistry
Medicine
Analytical Chemistry
Molecular Biology
Erratum To: CX3CR1 Deficiency Accelerates the Development of Retinopathy in a Rodent Model of Type 1 Diabetes
Journal of Molecular Medicine
Molecular Medicine
Drug Discovery
Genetics
Retinopathy at Diagnosis of Diabetes, With Special Reference to Patients Under 40 Years of Age
BMJ
Higher Levels of Prorenin Predict Development of Diabetic Retinopathy in Patients With Type 2 Diabetes
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal Medicine
Endocrinology